A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.

The FDA’s effort to crack down on compounded versions of popular GLP-1 weight-loss drugs has sparked backlash from patients and compounding pharmacies over concerns about access and ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...

Nourish, a virtual nutrition provider, is launching a program that gives patients access to free cardiometabolic lab testing. Nourish Labs will integrate blood testing into personalized nutrition care ...

AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay(TM) blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced ...

(NewsNation) — As weight loss drugs become increasingly popular, thousands of patients have filed lawsuits against the companies behind GLP-1 medications, alleging severe health effects. Since 2023, ...

Add Yahoo as a preferred source to see more of our stories on Google. At least 3,000 patients have filed lawsuits against the companies behind GLP-1 weight loss drugs, alleging severe health risks, ...

Whether you like them or not, weight-loss drugs have changed the world. Obesity levels in the US, which had been on the rise for years, are falling. National spend on food has shrunk, fashion outlets ...

After Effects test showing a 3D, Matrix digital computer effect using Trapcode. Canada's Carney fires back at Trump after Davos speech Astronauts speak out after being forced to evacuate from space ...

WASHINGTON — A tank built for Rocket Lab’s Neutron rocket was damaged during qualification testing, threatening to further delay the vehicle’s first flight. In a Jan. 21 statement, Rocket Lab said a ...